CYTOKINETICS INC company info

CIK 1061983
IRS Number 943291317
State of incorporation None
Business address 280 EAST GRAND AVENUE
.
SOUTH SAN FRANCISCO
CA
94080
Mail address 280 EAST GRAND AVENUE
None
SOUTH SAN FRANCISCO
CA
94080

Short summary

CYTOKINETICS INC is a California company, with head office located at 280 East Grand Avenue South San Francisco, California 94080. In 2018 the company owned a total of 198.22 million USD worth of assets, including 184.95 million USD worth of current assets. 2016 was the year when the company amassed the most assets.

CYTOKINETICS INC Income Statement

Name [in Millions USD]1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018Trends
Research and development 39.8438.0137.1835.6449.4544.4346.4059.9090.3089.14
Operating Expenses 64.5461.6966.0787.72126.76120.42
Operating Income (Loss) 26.10-49.64-47.96-40.46-33.89-14.75-37.4118.69-113.40-88.92
Interest expense 0.180.040.00000.272.703.023.80
Income Tax Expense (Benefit) 0.15-0.1800000
Net income -7.34-13.08-15.87-23.08-32.69-37.20-42.25-57.12-48.89-56.3724.54-49.29-47.86-40.37-33.72-14.65-37.5016.45-127.79-106.29

CYTOKINETICS INC Balance Sheet

Name [in Millions USD]1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 41.8218.3723.7763.6517.0612.3624.8427.72100.7146.9634.36
Accounts Receivable, Net, Current 0.020.248.99
Property, Plant and Equipment, Gross 24.1024.2922.2121.9622.5924.7626.1927.07
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 22.7923.2920.9920.3320.8421.1222.6323.86
Available-for-sale Securities, Noncurrent 7.6820.0902.25
Other Assets, Noncurrent 0.210.130.130.200.200.200.280.418.07
Total assets 72.1694.0894.5696.14112.71106.16340.63247.24198.22
Current assets 69.8092.9693.6280.08107.9096.62317.00244.23184.95
Accounts payable 1.011.051.800.991.602.851.781.345.19
Total current liabilities 5.513.9934.0516.9229.1126.2731.0627.2921.96
Long-term Debt, Excluding Current Maturities 029.6022.8430.6644.47
Long-term Debt 14.6430.1632.3742.59
Deferred Revenue, Noncurrent 80.778.291.2815.0700
Total liabilities 5.514.1042.5717.4537.8557.42165.63172.07203.11
Common Stock, Value, Issued 0.070.130.030.040.040.040.050.060.06
Retained Earnings (Accumulated Deficit) -385.99-427.38-476.54-499.72-516.67-558.81-573.24-688.22-804.80
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.02-0.00-0.000.010.010.23-0.090.450.76

CYTOKINETICS INC Cash Flow

Name [in Millions USD]1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018Trends
Net income -7.34-13.08-15.87-23.08-32.69-37.20-42.25-57.12-48.89-56.3724.54-49.29-47.86-40.37-33.72-14.65-37.5016.45-127.79-106.29
Depreciation 1.901.300.600.400.500.600.701.901.20
Depreciation and amortization 2.021.901.300.590.430.490.590.741.921.24
Deferred Income Tax Expense (Benefit) 0000
Accounts receivable -46.630.011.091.12
Deferred revenue -23.74-0.75016.2017.40-12.742.201.51
Net Cash Provided by (Used in) Operating Activities 8.42-44.83-45.60-33.44-7.72-101.76-101.22
Payments to Acquire Property, Plant, and Equipment 0.550.490.440.130.541.100.561.602.880.89
Net Cash Provided by (Used in) Investing Activities -53.4834.2425.30-28.82-1.52-65.835.13
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -28.82-1.52-4.0516.06-52.08-65.83
Proceeds from Issuance of Common Stock 43.687.4548.978.670112.220
Payments for Repurchase of Common Stock
Net Cash Provided by (Used in) Financing Activities 28.812.5521.6158.3314.49225.9213.13
Cash and Cash Equivalents, Period Increase (Decrease) -16.26-8.051.32-3.935.250.0644.861.8058.33